Literature DB >> 22926189

Cellular toxicity of mutant SOD1 protein is linked to an easily soluble, non-aggregated form in vitro.

Terrell E Brotherton1, Yingjie Li1, Jonathan D Glass2.   

Abstract

Mutations in superoxide dismutase 1 (SOD1) are found in approximately 20% of patients with familial amyotrophic lateral sclerosis. The propensity of mutant SOD1 to form aggregates in pathologically affected cells (i.e. motor neurons) has implicated these poorly soluble protein aggregates and/or their misfolded soluble precursors as being instrumental to the disease process. We investigated the relative solubility and toxicity of four different mutant SOD1 proteins in a cell-based model system and demonstrate that the mutant, misfolded SOD1 proteins that are the most soluble are also the most toxic. This toxicity was ameliorated by upregulating heat-shock protein chaperones in order to refold the soluble, misfolded protein, regardless of the presence of poorly soluble SOD1. We further demonstrate that increasing the solubility of a SOD1 mutant protein that is both poorly soluble and non-toxic, as compared to other mutant proteins, resulted in remarkably increased toxicity of the mutant SOD1. Again, this increased toxicity was attenuated by upregulating heat-shock protein chaperones in order to refold the soluble, misfolded proteins. These findings implicate easily soluble, misfolded SOD1 as being toxic to the cell and support the hypothesis that reducing solubility of mutant SOD1 proteins through aggregation may occur as a self-protective response in the cell.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggregation; Amyotrophic lateral sclerosis; Misfold; SOD1; Solubility

Mesh:

Substances:

Year:  2012        PMID: 22926189      PMCID: PMC3549044          DOI: 10.1016/j.nbd.2012.08.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  55 in total

1.  Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation.

Authors:  Heidrun Witan; Andreas Kern; Ingrid Koziollek-Drechsler; Rebecca Wade; Christian Behl; Albrecht M Clement
Journal:  Hum Mol Genet       Date:  2008-01-22       Impact factor: 6.150

Review 2.  Current status of SOD1 mutations in familial amyotrophic lateral sclerosis.

Authors:  M Gaudette; M Hirano; T Siddique
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-03

3.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

Authors:  J A Johnston; M J Dalton; M E Gurney; R R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 4.  The epidemiology of motor neuron diseases: a review of recent studies.

Authors:  P M Worms
Journal:  J Neurol Sci       Date:  2001-10-15       Impact factor: 3.181

5.  High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation.

Authors:  Jiou Wang; Guilian Xu; David R Borchelt
Journal:  Neurobiol Dis       Date:  2002-03       Impact factor: 5.996

6.  High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1.

Authors:  Zarah Batulan; Gayle A Shinder; Sandra Minotti; Bei Ping He; Mohammad M Doroudchi; Josephine Nalbantoglu; Michael J Strong; Heather D Durham
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

7.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

8.  Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.

Authors:  P Andreas Jonsson; Karin Ernhill; Peter M Andersen; Daniel Bergemalm; Thomas Brännström; Ole Gredal; Peter Nilsson; Stefan L Marklund
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

9.  Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes.

Authors:  Krishna Puttaparthi; Cezary Wojcik; Bhagya Rajendran; George N DeMartino; Jeffrey L Elliott
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

Review 10.  Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition.

Authors:  D M Walsh; I Klyubin; J V Fadeeva; M J Rowan; D J Selkoe
Journal:  Biochem Soc Trans       Date:  2002-08       Impact factor: 5.407

View more
  15 in total

1.  Cis-suppression to arrest protein aggregation in mammalian cells.

Authors:  Simpson Gregoire; Shaojie Zhang; Joseph Costanzo; Kelly Wilson; Erik J Fernandez; Inchan Kwon
Journal:  Biotechnol Bioeng       Date:  2013-10-18       Impact factor: 4.530

2.  Stathmin-2: adding another piece to the puzzle of TDP-43 proteinopathies and neurodegeneration.

Authors:  Jonathan D Glass
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

3.  Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis.

Authors:  Melissa Nassif; Vicente Valenzuela; Diego Rojas-Rivera; René Vidal; Soledad Matus; Karen Castillo; Yerko Fuentealba; Guido Kroemer; Beth Levine; Claudio Hetz
Journal:  Autophagy       Date:  2014-05-12       Impact factor: 16.016

4.  Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS.

Authors:  Sang Hwa Kim; Shannon G Stiles; Joseph M Feichtmeier; Nandini Ramesh; Lihong Zhan; Mark A Scalf; Lloyd M Smith; Udai Bhan Pandey; Randal S Tibbetts
Journal:  Hum Mol Genet       Date:  2018-01-15       Impact factor: 6.150

5.  Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1.

Authors:  Evangelos Kiskinis; Jackson Sandoe; Luis A Williams; Gabriella L Boulting; Rob Moccia; Brian J Wainger; Steve Han; Theodore Peng; Sebastian Thams; Shravani Mikkilineni; Cassidy Mellin; Florian T Merkle; Brandi N Davis-Dusenbery; Michael Ziller; Derek Oakley; Justin Ichida; Stefania Di Costanzo; Nick Atwater; Morgan L Maeder; Mathew J Goodwin; James Nemesh; Robert E Handsaker; Daniel Paull; Scott Noggle; Steven A McCarroll; J Keith Joung; Clifford J Woolf; Robert H Brown; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633

Review 6.  Metal-deficient SOD1 in amyotrophic lateral sclerosis.

Authors:  James B Hilton; Anthony R White; Peter J Crouch
Journal:  J Mol Med (Berl)       Date:  2015-03-11       Impact factor: 4.599

7.  Viral vector gene delivery of the novel chaperone protein SRCP1 to modify insoluble protein in in vitro and in vivo models of ALS.

Authors:  Ian W Luecke; Gloria Lin; Stephanie Santarriaga; K Matthew Scaglione; Allison D Ebert
Journal:  Gene Ther       Date:  2021-07-08       Impact factor: 5.250

8.  Functional contribution of the transcription factor ATF4 to the pathogenesis of amyotrophic lateral sclerosis.

Authors:  Soledad Matus; Estefanía Lopez; Vicente Valenzuela; Melissa Nassif; Claudio Hetz
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

Review 9.  An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis.

Authors:  Melissa S Rotunno; Daryl A Bosco
Journal:  Front Cell Neurosci       Date:  2013-12-16       Impact factor: 5.505

10.  ALS-linked misfolded SOD1 species have divergent impacts on mitochondria.

Authors:  Sarah Pickles; Sabrina Semmler; Helen R Broom; Laurie Destroismaisons; Laurine Legroux; Nathalie Arbour; Elizabeth Meiering; Neil R Cashman; Christine Vande Velde
Journal:  Acta Neuropathol Commun       Date:  2016-04-27       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.